The U.S. Centers for Disease Control and Prevention estimates nearly 13 million people in the U.S. have “latent TB infection.

Drug resistance in Mycobacterium tuberculosis arises from the man-made selection of mutants that result from spontaneous chromosomal alterations. Preventing the development of drug-resistant TB ...

Global health experts warn that US retreat from TB prevention programs could lead to a resurgence of the deadliest infectious ...

Approved in 2012 by the U.S. Food and Drug Administration (FDA), bedaquiline was the first new TB drug in more than 40 years. It works well against multidrug-resistant TB strains, but the ...

The World Health Organization says nearly 11 million people around the world were diagnosed with tuberculosis in 2023. Author ...

In 2021 alone, 450,000 people developed multidrug-resistant tuberculosis, with treatment success rates dropping to just 57%, according to the World Health Organization. Now, Tulane University ...

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...

Study Finds Three New Safe, Effective Ways to Treat Drug-Resistant Tuberculosis Jan. 29, 2025 — Study finds three new safe and effective drug regimens to fight multidrug-resistant TB.

The Stop TB Partnership's Global Drug Facility (GDF) has cut the price of a key component of multidrug-resistant tuberculosis ...

Health officials in Montana confirmed the state's first-ever case of the fungal infection Candida auris this week.The fungal ...